SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Santiago Palacio, Robert G. Hart, Lesly A. Pearce, David C. Anderson, Mukul Sharma, Lee A. Birnbaum, Oscar R. Benavente, Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials, International Journal of Stroke, 2015, 10, 1
  2. 2
    Christopher A. Pickett, Todd C. Villines, Michael A. Ferguson, Edward A. Hulten, Cost Effectiveness of Percutaneous Closure Versus Medical Therapy for Cryptogenic Stroke in Patients With a Patent Foramen Ovale, The American Journal of Cardiology, 2014, 114, 10, 1584

    CrossRef

  3. 3
    Keun-Sik Hong, Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons, Journal of Clinical Neurology, 2014, 10, 3, 189

    CrossRef

  4. 4
    C. Keith Ozaki, Piotr S. Sobieszczyk, Karen J. Ho, James T. McPhee, Edwin C. Gravereaux, Evidence-based carotid artery–based interventions for stroke risk reduction, Current Problems in Surgery, 2014, 51, 5, 198

    CrossRef

  5. 5
    Marina Panova-Noeva, Marina Marchetti, Laura Russo, Carmen J. Tartari, Anna Leuzzi, Guido Finazzi, Alessandro Rambaldi, Hugo ten Cate, Anna Falanga, ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera, Thrombosis Research, 2013, 132, 1, 88

    CrossRef

  6. 6
    Rhynn J. Malloy, Abir O. Kanaan, Matthew A. Silva, Jennifer L. Donovan, Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis, Clinical Therapeutics, 2013, 35, 10, 1490

    CrossRef

  7. 7
    Sarkis G. Morales Vidal, Sean Ruland, Platelet Antiaggregants in Stroke Prevention, Neurologic Clinics, 2013, 31, 3, 633

    CrossRef

  8. 8
    Piotr Sobieszczyk, Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease, 2013,

    CrossRef

  9. 9
    Kirtiman Srivastava, Philip M. W. Bath, Ulvi Bayraktutan, Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke, Cellular and Molecular Neurobiology, 2012, 32, 3, 319

    CrossRef

  10. 10
    Wilhelm Kuker, Jonathan Downer, Martino Cellerini, Dennis Briley, Ursula Schulz, Fatal brainstem haemorrhage after intracranial stenting: how much anti-platelet medication should we give?, Neuroradiology, 2011, 53, 7, 545

    CrossRef

  11. 11
    Peter M Rothwell, Ale Algra, Pierre Amarenco, Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke, The Lancet, 2011, 377, 9778, 1681

    CrossRef

  12. 12
    Helmi Lutsep, Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke, Expert Review of Cardiovascular Therapy, 2011, 9, 10, 1295

    CrossRef

  13. 13
    Nyoli Valentine, Floris A Van de Laar, Mieke L van Driel, Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus, The Cochrane Library,
  14. 14
    Ayeesha K Kamal, Shaista A Siddiqi, Imama Naqvi, Maria Khan, Farzin Majeed, Bilal Ahmed, Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack, The Cochrane Library,